IL13 and visceral leishmaniasis: Since both IL-4 and IL-13 share a common signaling pathway through the IL-4Rα chain, collectively modulating type 2 immunity, IL-4Rα-mediated mechanisms became our primary research interest, in cutaneous and visceral leishmaniasis (7–9, 80) and extending to acute schistosomiasis (81–83), nematode infections (84–86), and allergic airway disease (87, 88).